期刊文献+

绝经前乳腺癌辅助内分泌治疗的现状和展望 被引量:5

Current Status and Prospect in Adjuvant Endocrine Therapy for Pre-menopausal Women with Breast Cancer
下载PDF
导出
摘要 三苯氧胺(TAM)服用5年是绝经前受体阳性乳腺癌术后辅助内分泌治疗的标准治疗。卵巢去势可用于对TAM有使用禁忌的患者。药物卵巢去势其有效性等同于手术去势,治疗结束后卵巢功能可能恢复。卵巢去势联合TAM可用于年轻的中高危复发患者、化疗不能诱导去势的高危复发患者。卵巢去势联合芳香化酶抑制剂作为临床常规辅助治疗有待于足够的临床研究证据,医生在临床实践中,可讨论用于部分不适合TAM治疗和/或有高危复发因素的患者。绝经前乳腺癌术后辅助内分泌治疗还有很多未解决的问题。更多的临床试验结果将为我们的临床实践提供充分的证据。
作者 杨红健
机构地区 浙江省肿瘤医院
出处 《中国肿瘤》 CAS 2007年第10期797-800,共4页 China Cancer
  • 相关文献

参考文献7

  • 1Early Breast Cancer Trialist's Collaborative Group(EBCTCG).Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival:an overview of the randomised trials[J].Lancet,2005,365(9472):1687-1717.
  • 2Kaufmann M,Jonat W,Blamey R,et al.Survival analysis from the ZEBRA study:goserelin (Zoladex)versus CMF in premenopausal women with nodepositive breast cancer[J].Eur J Cancer,2003,39(12):1711-1717.
  • 3Baum M,Hackshaw A,Houghton J,et al.Adjuvant goserelin in pre-menopausal patients with early breast cancer:Results from the ZIPP study[J].Eur J Cancer,2006,42(7):895-904.
  • 4Davidson NE,O'Neill AM,Vukov AM,et al.Chemoendocrine therapy for premenopausal women with axillary lymph node-positive,steroid hormone receptor-positive breast cancer:results from INT 0101(ES188)[J].J Clin Oncol,2005,23(25):5973-5982.
  • 5Jakesz R,Hausmaninger H,Kubista E,et al.Randomized adjuvant trial of tomoxifen and goserelin versus cyclophosphamide,methotrexate,and fluorouracil:evidence for the superiority of treatment with endocrine blockade in premenopausal patients with hormone-responsive breast cancer--Austrian Breast and Colorectal Cancer Study Group Trial 5[J].J Clin Oncol,2002,20(24):4621-4627.
  • 6Francis P,Fleming G,Nasi ML,et al.Tailored treatment investigations for premenopausal women with endocrine responsive (ER+ and/or PgR+) breast cancer:the SOFT,TEXT,and PERCHE trials[J].Breast,2003,12(Suppl 1):S44.
  • 7LHRH-agonists in Early Breast Cancer Overview group,Cuzick J,Ambroisne L,et al.Use of luteinisins-hormone-releasing hormone agonists as adjuvant treatment in premenopausal patient with hormone-receptor-positive breast cancer:a meta-analysis of individual patient data from randomized adjuvant trials[J].Lancet,2007,369(9574):1711-1723.

同被引文献43

引证文献5

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部